Abstract
The development of a new active pharmaceutical ingredient involves different steps, and many opportunities for the generation of impurities may arise. The safety of the drug depends not only on the toxicological properties of the active pharmaceutical ingredient itself, but on the impurities it contains. For this reason, accurate assessment of impurity profiles of active pharmaceutical in…